Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,711,919
+$1,103,733 QoQ
Shares Held
26,428
+15.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.10%
of 13F equity value
Holder Rank
#1,381
of 4,664 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrive Capital Management, LLC holds $24,319,388 across 7 Drug Manufacturers - General names. JNJ ranks #1 (27.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
26,428 | $6,711,919 | |
| 2 | MRK |
Merck & Co., Inc.
|
42,844 | $5,505,454 | |
| 3 | LLY |
ELI LILLY & Co
|
4,356 | $5,224,717 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
34,523 | $4,361,635 | |
| 5 | AMGN |
Amgen Inc
|
4,477 | $1,621,211 | |
| 6 | ABBV |
AbbVie Inc.
|
1,905 | $479,374 | |
| 7 | AZN |
Astrazeneca PLC
|
2,189 | $415,078 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,711,919 | 26,428 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,608,186 | 22,943 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $5,329,376 | 25,752 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,348,069 | 28,843 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $3,911,316 | 25,606 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,522,426 | 15,210 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,156,331 | 21,825 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,602,845 | 16,061 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,527,106 | 17,290 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,146,321 | 13,568 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,157,524 | 7,385 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $1,100,996 | 7,069 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,201,675 | 7,260 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,001,610 | 6,462 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,108,125 | 6,273 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $923,474 | 5,653 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,004,529 | 5,659 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,066,038 | 6,015 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,622,770 | 9,486 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,807,185 | 11,190 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,917,738 | 11,641 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,865,865 | 11,353 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,791,928 | 11,386 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||